NAD+ Report

Route and milligrams first, then the price

NAD+ IV vs injection

One is a session in a chair with a nurse attached to it, priced per session and dosed per session. The other is a vial and a box of syringes you use at home, priced per month and dosed per dose. Both are sold as NAD+. Neither price means anything next to the other until you have the milligrams and the cycle for both.

What each one is actually buying

The drip
Chair time, a nurse, the consumables, and a room to sit in for as long as it takes. The NAD+ is a line item inside a service. That is why a single session can cost more than a month of the other thing without either figure being unreasonable — they are not paying for the same list.
The injection
A vial, syringes, and usually a consult wrapped into a subscription. The labor is yours. What you are buying is the drug, the fulfillment and the prescription, and the supervision line is simply not on the invoice because it is not in the product.

The comparison trap

A clinic quotes per session. A telehealth seller quotes per month. Put those two figures side by side and you are comparing a unit price to a subscription, which tells you nothing. To compare them at all you need three things from each seller, and a surprising number of pages give you one or two:

With all three you can put both sellers on the same denominator. Without them you are guessing, and the guess will usually favor whoever wrote the larger number in the smaller font. The board on the home page carries the route, the milligrams and the cycle for every row precisely so this arithmetic is possible.

The claim this page will not make

Sellers on both sides argue that their route delivers more of what you paid for. IV pages point at going straight into a vein; subcutaneous pages point at steadier exposure over a week. Those are claims about what reaches circulation and how quickly, they are the load-bearing claims in the entire category, and this site has not sourced them. [needs citation] So it does not repeat them, in either direction, and you should treat a seller that states one as a fact without a citation the way you would treat any other unsourced number on a checkout page.

What can be said without a source is duller and more useful: the two routes differ in who is in the room, how often you do it, what happens if something feels wrong, and what the invoice covers. Those differences are real, checkable on the seller’s own pages, and they are usually enough to decide.

Where the nasal spray and the capsule sit

Two more things get sold into the same search results. A nasal spray, which is a third route and which most sellers price without ever saying how many milligrams a spray delivers. And an oral capsule of NMN or NR, which is a precursor the body converts rather than NAD+ itself — a different molecule, a legitimate category, and not the thing an IV-versus-injection comparison is about. This site keeps the capsule on the same board, marked, so that its price is never quietly read as a cheaper version of the drip.

How to choose without a clinical claim

You are picking a delivery model before you are picking a molecule. A drip is an appointment: someone else handles it, you travel to it, you pay per occasion. An at-home injection is a routine: you handle it, it is cheaper per occasion, and the responsibility for noticing a problem is yours. Which of those two you can actually sustain for three months is a better predictor of how this goes than anything on either seller’s landing page.

This is not medical advice. Nobody here is a clinician, this site runs no clinical review, and none of it should be read as a recommendation to take or avoid anything. Decisions about NAD+ belong with a licensed clinician who has your history in front of them.

The other two